💊 ALEMBIC PHARMA GETS USFDA NOD FOR ACNE TREATMENT DRUG

• 🇺🇸 Received USFDA Final Approval for Tretinoin Cream USP, 0.05% • 🧴 Product is the generic equivalent of Retin-A Cream 0.05% of Bausch Health • 🎯 Used for the treatment of acne vulgaris • 💰 Addressable U.S. market size estimated at $76 million (MAT March 2026) • 📈 Alembic now has a total of 242 ANDA approvals from USFDA, including 222 final approvals 🟢 Impact: Positive (Strengthens Alembic's U.S. dermatology portfolio and supports growth in the generics business)

ALEMBIC PHARMA LTD

← Back to feed